Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Hollinshead

Showing results (11-20 of 19) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 19 results.
Cell Reports|October 7, 2020
Respiratory Supercomplexes Promote Mitochondrial Efficiency and Growth in Severely Hypoxic Pancreatic CancerKate E R Hollinshead, Seth J Parker, Vinay V Eapen, et al.
Nature Communications|August 13, 2021
Spontaneous hydrolysis and spurious metabolic properties of α-ketoglutarate estersSeth J Parker, Joel Encarnación-Rosado, Kate E R Hollinshead, et al.
Nature Communications|November 3, 2015
Loss of succinate dehydrogenase activity results in dependency on pyruvate carboxylation for cellular anabolismCharlotte Lussey-Lepoutre, Kate E R Hollinshead, Christian Ludwig, et al.
Nature Communications|July 28, 2025
Inhibition of HDAC6 alters fumarate hydratase activity and mitochondrial structureAndrew Roe, Catríona M Dowling, Cian D'Arcy, et al.
Cell|July 3, 2020
Niche-Selective Inhibition of Pathogenic Th17 Cells by Targeting Metabolic RedundancyLin Wu, Kate E R Hollinshead, Yuhan Hao, et al.
Cell Reports|March 22, 2018
Oncogenic IDH1 Mutations Promote Enhanced Proline Synthesis through PYCR1 to Support the Maintenance of Mitochondrial Redox HomeostasisKate E R Hollinshead, Haydn Munford, Katherine L Eales, et al.
Cancer Discovery|April 29, 2020
Selective Alanine Transporter Utilization Creates a Targetable Metabolic Niche in Pancreatic CancerSeth J Parker, Caroline R Amendola, Kate E R Hollinshead, et al.
Science Advances|February 1, 2021
Multiple screening approaches reveal HDAC6 as a novel regulator of glycolytic metabolism in triple-negative breast cancerCatríona M Dowling, Kate E R Hollinshead, Alessandra Di Grande, et al.
Cancer Research|July 11, 2020
Epigenetic CRISPR Screens Identify <i>Npm1</i> as a Therapeutic Vulnerability in Non-Small Cell Lung CancerFei Li, Wai-Lung Ng, Troy A Luster, et al.
Pageof 2

Showing results (11-20 of 19) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 19 results.
Cell Reports|October 7, 2020
Respiratory Supercomplexes Promote Mitochondrial Efficiency and Growth in Severely Hypoxic Pancreatic CancerKate E R Hollinshead, Seth J Parker, Vinay V Eapen, et al.
Nature Communications|August 13, 2021
Spontaneous hydrolysis and spurious metabolic properties of α-ketoglutarate estersSeth J Parker, Joel Encarnación-Rosado, Kate E R Hollinshead, et al.
Nature Communications|November 3, 2015
Loss of succinate dehydrogenase activity results in dependency on pyruvate carboxylation for cellular anabolismCharlotte Lussey-Lepoutre, Kate E R Hollinshead, Christian Ludwig, et al.
Nature Communications|July 28, 2025
Inhibition of HDAC6 alters fumarate hydratase activity and mitochondrial structureAndrew Roe, Catríona M Dowling, Cian D'Arcy, et al.
Cell|July 3, 2020
Niche-Selective Inhibition of Pathogenic Th17 Cells by Targeting Metabolic RedundancyLin Wu, Kate E R Hollinshead, Yuhan Hao, et al.
Cell Reports|March 22, 2018
Oncogenic IDH1 Mutations Promote Enhanced Proline Synthesis through PYCR1 to Support the Maintenance of Mitochondrial Redox HomeostasisKate E R Hollinshead, Haydn Munford, Katherine L Eales, et al.
Cancer Discovery|April 29, 2020
Selective Alanine Transporter Utilization Creates a Targetable Metabolic Niche in Pancreatic CancerSeth J Parker, Caroline R Amendola, Kate E R Hollinshead, et al.
Science Advances|February 1, 2021
Multiple screening approaches reveal HDAC6 as a novel regulator of glycolytic metabolism in triple-negative breast cancerCatríona M Dowling, Kate E R Hollinshead, Alessandra Di Grande, et al.
Cancer Research|July 11, 2020
Epigenetic CRISPR Screens Identify <i>Npm1</i> as a Therapeutic Vulnerability in Non-Small Cell Lung CancerFei Li, Wai-Lung Ng, Troy A Luster, et al.
Pageof 2